- Home
- NSSC vs COLL Comparison
NSSC vs COLL Comparison
Compare NSSC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- COLL
- Stock Information
- Founded
- NSSC 1969
- COLL 2002
- Country
- NSSC United States
- COLL United States
- Employees
- NSSC N/A
- COLL N/A
- Industry
- NSSC Telecommunications Equipment
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- NSSC Telecommunications
- COLL Health Care
- Exchange
- NSSC Nasdaq
- COLL Nasdaq
- Market Cap
- NSSC 899.1M
- COLL 910.2M
- IPO Year
- NSSC N/A
- COLL 2015
- Fundamental
- Price
- NSSC $24.27
- COLL $30.07
- Analyst Decision
- NSSC Strong Buy
- COLL Strong Buy
- Analyst Count
- NSSC 5
- COLL 5
- Target Price
- NSSC $37.00
- COLL $43.60
- AVG Volume (30 Days)
- NSSC 468.4K
- COLL 506.2K
- Earning Date
- NSSC 05-05-2025
- COLL 05-08-2025
- Dividend Yield
- NSSC 2.06%
- COLL N/A
- EPS Growth
- NSSC 12.99
- COLL 43.56
- EPS
- NSSC 1.31
- COLL 1.86
- Revenue
- NSSC $186,533,000.00
- COLL $631,449,000.00
- Revenue This Year
- NSSC N/A
- COLL $19.43
- Revenue Next Year
- NSSC $10.64
- COLL $3.34
- P/E Ratio
- NSSC $18.53
- COLL $16.17
- Revenue Growth
- NSSC 5.14
- COLL 11.41
- 52 Week Low
- NSSC $23.00
- COLL $27.28
- 52 Week High
- NSSC $58.09
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- NSSC 39.93
- COLL 54.22
- Support Level
- NSSC $23.31
- COLL $29.25
- Resistance Level
- NSSC $24.70
- COLL $30.84
- Average True Range (ATR)
- NSSC 0.83
- COLL 1.03
- MACD
- NSSC 0.21
- COLL 0.20
- Stochastic Oscillator
- NSSC 39.02
- COLL 79.14
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.